stem cell therapy alzheimers dementia

Stem Cell Treatment for Alzheimer’s, Vascular & Lewy bodies

Alzheimer’s is also known in medical literature as Alzheimer’s Disease (AD) is the most common type of dementia. As of Today, there are no effective pharmaceutical-based therapies for the illness.

The condition is terminal, and if left untreated will eventually lead to death. AD is generally diagnosed in older adults, aged sixty-five years plus, but of course; it can also occur in an earlier age. In 2020, an estimated 59 million people were suffering from AD throughout the world. Alzheimer’s is predicted to affect one in every eighty individuals globally by the year 2040.[1]  As recently as last year, the diagnosis of has quickly skyrocketed to become the fifth largest cause of death worldwide. Alzheimer’s makes up about 70% of these cases.  Some medical researchers have also recently begun to consider the possibility of Alzheimer’s being an autoimmune brain disease. and patients with Axial spondyloarthritis have a higher chance of getting diagnosed with Alzheimer’s dementia. Alzheimers disease is currently diagnosed based on several factors including amyloid plaques and tau tangles “neurofibrillary tangles” (NFTs) which are toxic proteins in the brain tissue and result in cognitive decline and eventually dementia. These self-propagating prion proteins are amyloid beta (A-β) and tau. Patients with higher levels of these prions and beta amyloid plaque are associated with early-onset Alzheimers. New studies have also found over 215 genes that counter ApoE2 protection and ApoE4 risk. For some patients the, expression was linked to genome-wide association study variants and focused on genes involved in the synaptic function, regulation of lipoproteins, and neuroinflammation.

What are Prions & Double-Prion Disorders?

Amyloid Plaques and Neurofibrillary Tangles – Prions are defective proteins that spread similar to infections in the human body. These proteins force good copies of proteins into the broken misfolded shapes that destroy the brain. The Double-prion-Disorders-alzheimers double-prion disorder refers to the two rogue proteins Tau and amyloid beta. Recent research has shown clear underlying causes of neurodegenerative diseases caused by a consistent buildup of misfolded tau proteins (β amyloid plaques and tangles) that are sometimes referred to as “prion-like” and can now be measured much quicker than in the past. Other identified Prion Diseases include: Creutzfeldt-Jakob Disease (CJD), Gerstmann-Straussler-Scheinker Syndrome, Kuru disease, Variant Creutzfeldt-Jakob Disease (vCJD) and Fatal Familial Insomnia

Signs & Symptoms of Alzheimer’s

Alzheimers show a wide variety of symptoms, including personality changes, memory loss followed by severely impaired intellectual/cognitive functions that arise from the disease itself or from any trauma to the brain tissue. Such symptoms are NOT part of the normal aging cycle and are usually severe enough to impact the daily activities, relationships, and independence of the affected persons. Alzheimer’s “AD” is the most commonly known type of dementia, but there are other diagnosed forms of neurodegenerative disease, including vascular and mixed dementia.

Difference between Dementia and Alzheimer’s

Patients with dementia usually have a rapid decline in memory function, learning, communication, and solving simple problems. For some, these changes take several years to occur, but for many, the neurological function deteriorates very quickly and if left untreated, will not be reversible.

The rate of progression and eventual outcome of TDP-43 proteinopathy, AD and dementia vary patient to patient but is usually determined by the area of the brain that is affected and the type of dementia which they are diagnosed with.[2] Early diagnosis and treatment are the patient’s best hope. Thanks to modern tests for the disease, early detection is quite simple using advanced brain imaging such as CT Scans, MRI’s, clinical examinations from approved neurologists, and other diagnostic tests including DNA Screenings.

Typical symptoms & signs of Double-prion Disorders such as ALZ:

  • Loss of communication skills
  • Rapid Memory loss
  • Motor Function, Gait and balance issues
  • Difficulty making decisions
  • Difficulty with abstract thoughts
  • Faulty reasoning
  • Senile behavior due to cognitive impairment
  • Inappropriate verbal and physical behavior
  • Impaired judgment
  • Sundowners Syndrome
  • Autonomic neuropathy
  • Disorientation of time and location
  • Paranoia, frequent agitation or Hallucinations
  • Complete neglect of personal hygiene and safety

People with Neuro Degenerative Alzheimer’s might also:

  • Asks the same question repeatedly
  • Cannot recognize family or friends
  • Unable to remember or follow directions
  • Frequent cognitive impairment ie lost or disoriented in very familiar places

Sundown Syndrome

Sundowning or “late-day confusion” is a common neurological symptom of Alzheimer’s disease. Patients and family members taking care of patients with the disease need to be aware that confusion and frequent agitation might depend on the time of day. The most dangerous type of Sundowning behavior includes persistent Hallucinations or wandering away from home. Sundowners often experience pronounced symptoms in the late afternoon or evening.  Sundowning usually occurs in middle-stage to advanced ALZ.


4 Types of Dementia

Disease symptoms are often very similar, which is why there is often trouble determining which type of dementia a patient might have. To make matters more complicated, some patients experience multiple types of overlapping symptoms and therefore, get diagnosed with “mixed dementia.” There are also cases of familial Dementia; however, the odds are very low ( less than 5% of all cases), and genetic testing can be done to confirm or deny hereditary involvement. The four most common forms of dementia are:

  1. Alzheimer’s Disease generally occurs after a rapid buildup of tau tangles or amyloid plaque proteins (tau protein) & β amyloid plaque in the brain – amyloid cascade hypothesis.
  2. Lewy Body occurs when abnormal amyloid precursor protein appear in nerve cells and result in impaired cell signaling or function.
  3. Frontotemporal – occurs when the temporal or frontal lobes of the human brain shrink or get damaged.
  4. Vascular – usually occurs after damage to the central nervous system after a brain stroke.

Stem Cell Treatment for Alzheimer’s

Alzheimer’s disease distinctly affects each patient, and there are still the usual indicators that one is suffering from the disease. Early warning signs are more usually misconceived to be a normal aging process or just manifestations of stress and depression. In the initial stage, the most common symptoms you can observe are difficulty in remembering current happenings. Potential before-after-neural-stem-cell-transplants Parkinson’s Disease and AD patients can be diagnosed and verified through examinations that gauge behavior and thinking abilities, followed with a more thorough examination of Radiology scans of the brain. As the diseases become more apparent, the warning signs can include being frustrated quickly, irritated easily, growing much more hostile, wild mood swings, difficulty in speech, language and the long-term loss of memory. Scientists have found that as the patient becomes more and more affected, they usually begin to isolate themselves from their family and the community. The body is affected gradually, and unfortunately, the brain inflammation and systemic shutdown can lead to death.

Like ALS Disease, Alzheimers and dementia displayed symptoms can be similar to patients with SMA, multiple sclerosis and Ataxia. Atherosclerosis (hardened arteries) is another common problem that leads to ischemic heart attacks, CAD, strokes, arthritis, peripheral vascular disease which results in having a very high risk of developing Alzheimer’s disease. Consequently, due to so many variables, this makes it harder to predict how it will play out. AD could worsen without the patient’s knowledge and be left undiscovered for a long time. The usual lifespan for people diagnosed with Alzheimer’s is roughly three to seven years. According to Alzheimer researchers Less than three percent of patients can live up to fourteen years or longer after being diagnosed with AD.[3] This is the stage where enhanced mesenchymal stemcells can be used to treat Alzheimer’s disease. Learn more about cellular therapies

Neural Stem Cell Treatment for Dementia – 2023 Protocol

There are a few medications that have been researched and approved for the treatment of cognitive symptoms due to Alzheimer’s disease including cholinesterase inhibitors (Exelon, Aricept, Razadyne) and memantine HCl (Namenda). Side effects of these medications include vomiting, loss of appetite, nausea, constipation, confusion, dizziness, headaches, and chronic bowel movements. For those with early onset Alzheimer’s or who have not responded well to traditional ALZ medications, The Regeneration Center offers a unique and effective treatment plan to repair brain damage caused by Lewy body. Our functional therapies use multiple types of cellular lines, neurotrophic growth factors along with exogenous and endogenous cells to induce synaptogenesis which then helps to replenish damaged/lost neuronal connection/signal systems and helps reduce amyloid plaque in the hippocampus region of the brain. Endogenous cultured cells from human umbilical cord offer anti inflammatory,immunomodulation capacity with anti-apoptotic activity and introduce neurogenic properties to the damaged regions from the human brain where they proliferate and mature into neurotransmitters, tnf α and functional derived neurons. Sensory precursor cells and nerve growth factors can be given intravenously or directly implanted to central nervous system areas to help promote the very of the patient.

Play Video about comparison-mesenchymal-stemcell-sources-viability-potency-regen

Can stem cells improve memory?

There is also substantial proof that transplanted brain cells or the neural precursor cells (NPCs) can survive and gradually develop into neurons, oligodendrocytes, and astrocytes ( via a process known as neurogenesis. Stemcells from dental pulp and cord tissue derived MSC+ for replacement of lost and damaged function. Other cellular lineages needed for neurodegenerative disorders include neuron progenitor cells to help induce endogenous neural precursors, help boost the structural neuroplasticity, vascular endothelial growth factors and nerve growth factors to increase pro-inflammatory cytokines such as tnf α and Interleukin1 beta (IL to halt neuronal apoptosis.[4]

What role do stem cells play in Alzheimer’s disease?

To push growth factors into the brain, somatic motor neurons can also be modified using cell growth factors. Studies indicate that the full-grown brain of the mammals preserves the capability to produce new neurons from the neural stem or progenitor cells. Stemcells for memory loss is one of the most practical and effective ways to bypass the blood brain barrier and being repair to the damage in the entorhinal cortex caused by brain Injuries, brain fog, Strokes, Alzheimer’s (to improve memory), help to restore intellectual function with quality of life for the patient affected by the disease.[5]

Neural Stem cells and isolated exosomes extracellular vesicles provide the potential to repair the damage caused by Alzheimer’s and improvement in the cognitive function of patients affected with brain injuries and motor neuron disease.

Treatment Warning & Risk Factors – Mesenchymal stem cell transplants for neurological and spinal conditions are not appropriate for all cases. Patients with older diagnosis, unidentifiable tissue damage, travel restrictions, or late stage diagnosis (high risk) may not qualify. The Regeneration Center does not offer Gene therapy, induced pluripotent stem cells (iPSC) or embryonic stem cells for treatment of Alzheimer’s disease or vascular dementia. Contact us for more details and learn about alzheimer friendly MIND diet.

Cost of Stem Cell Therapy for Alzheimer’s disease

Approved treatment protocol for Alzheimer’s disease using mesenchymal stem cell transplantation with neural progenitor cells will require a minimum of 14-18 days in Bangkok. Due to varying degrees of cognitive and physical degeneration, our team will need to review any patient health files before acceptance. Once our review is complete we can offer a detailed treatment plan that includes the complete treatment steps, including the types & quantities of pluripotent stem cells, treatment costs and total nights required for treatment.

Rehabilitation Post-Therapy – Physical rehab sessions after treatment is optional but highly recommended in Thailand or your home country. Living with ALZ disease is challenging and depending on the patients timing constraints, physical rehab can be provided upon request for 2-4 hours per day and up to 6 days per week. 
In addition, visas and extended stay accommodations at a hotel or furnished apartments for the patient and family can also be provided upon request.

To begin the qualification process for our multistage regenerative medicine protocol please prepare your recent health records & radiology scan from Brain MRI’s, PET scan or CT Scan and contact us today.

Published Clinical Citations

  • [1] ^ Blurton-Jones, Mathew, Brian Spencer, Sara Michael, Nicholas A Castello, Andranik A Agazaryan, Joy L Davis, Franz-Josef Müller, Jeanne F Loring, Eliezer Masliah, and Frank M LaFerla. 2014. Neural stem cells genetically-modified to express neprilysin reduce pathology in Alzheimer transgenic models. Human umbilical cord Stem cell research & therapy, no. 2 (April 16). doi:10.1186/scrt440.

  • [2] ^ Cook, Casey, Yong-jie Zhang, Ya-fei Xu, Dennis W Dickson, and Leonard Petrucelli. 2008. TDP-43 in neurodegenerative disorders. Expert opinion on biological therapy, no. 7. doi:10.1517/14712598.8.7.969.

  • [3] ^Suksuphew S, Neural stem cells could serve as a therapeutic material for age-related neurodegenerative diseases in Thailand. World Journal of Stem Cells. 2015;7(2):502–511. doi: 10.4252/wjsc.v7.i2.502.

  • [4] ^ Taupin P. Adult neural stem cells, neurogenic niches, and cellular therapy. Stem Cell Rev. 2006;2(3):213–219

  • [5] ^ Fitzsimons, Carlos P, Emma van Bodegraven, Marijn Schouten, Roy Lardenoije, Konstantinos Kompotis, Gunter Kenis, Mark van den Hurk, et al. 2014. Epigenetic regulation of adult neural stem cells: implications for Alzheimer’s disease. Molecular neurodegeneration (June 25). doi:10.1186/1750-1326-9-25.

Page last updated on 18 March 2023 | Topic last reviewed: 15 March 2022